Gary J. Nabel - Aug 8, 2022 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Director
Signature
/s/ John Canepa, as Attorney-In-Fact for Gary Nabel
Stock symbol
CADL
Transactions as of
Aug 8, 2022
Transactions value $
$0
Form type
4
Date filed
8/10/2022, 08:05 AM
Previous filing
Jun 24, 2022
Next filing
May 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CADL Stock Option (Right to Buy) Award $0 +28.5 K $0.00 28.5 K Aug 8, 2022 Common Stock 28.5 K $3.38 Direct F1

Explanation of Responses:

Id Content
F1 33% of the shares underlying this option shall vest and become exercisable on August 8, 2023, with the remainder vesting in two (2) equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date.